Non-Invasive Cancer Diagnostics Market

Non-Invasive Cancer Diagnostics Market Growing
Automation in Healthcare to Benefit Growth of the
Market
Non-invasive cancer diagnostics are procedures used for the identification of cancer without
incision in the body. Detection and treatment of cancer at early stages are important for longterm survival. Non-invasive cancer detection method is found to be an increasing choice of
interest, owing to its painless or minimal pain method of diagnostic coupled with more accurate
results. Molecular based diagnostic methods are expected to increase during the forecast period
due to launches of new biomarker based detection methods. Moreover, factors like increasing
incidence of cancer, increasing cancer screening rate, government initiatives, and emerging
technologies such as next generation sequencing are expected to drive the market during the
forecast period.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1651
According to Cancer Research UK, currently no diagnostic tests are 100% sensitive in general
practice. This suggests the unmet demand for novel diagnostic assay with more efficiency. The
efficiency of molecular diagnostics for screening of blood and tissue sample for cancer detection
fuels the research and development of biomarker based molecular diagnostic method, which can
detect abnormalities in their early developmental cycle. Moreover, according to Genome Biology
article published in 2017, the current research in non-invasive cancer detection are targeting
two class of studies - the development of biomarkers for a specific cancer type and the
characterization of circulating tumor DNA (ctDNA) for general cancer detection, without trying
to predict specific cancer types. Such studies will help manufacturers to develop better cancer
detection kits for molecular based diagnostics.
Non-Invasive Cancer Diagnostics Market Drivers
Increasing incidence of cancer is expected to be a major factor driving growth of non-invasive
cancer diagnostics market. Cancer is a major factor impacting the world economy. For instance,
according to the National Cancer Institute (NIH), cancer incidence was 439.2 per 100,000
individuals based on the cancer cases that occurred between 2011 and 2015. The same source
estimated that rate of cancer survivors in the U.S. were 15.5 million, which is expected to
increase to 20.3 million by 2026.
Increasing rate of cancer detection will also boost the non-invasive cancer diagnostics market
growth. According to the U.S. Breast Cancer Surveillance Consortium (BCSC) researchers, the
rate of cancer detection increased to 34.7 per 1,000 individuals in 2013, as compared to 25.3
per 1,000 individuals in 2005. Furthermore, governmental and non-governmental organizations
are engaged in raising awareness for breast and cervical cancer as well as conducts screening
programme. The National Institute for Health and Care Excellence (NICE) is involved in
improving diagnosis rate by revising draft guideline for early cancer detection. Moreover,
increasing cancer studies for cancer drug development will boost the non-invasive cancer
diagnostics market growth. In 2016, NCI's Center to Reduce Cancer Health Disparities launched
the National ‘Screen to Save’ Colorectal Cancer Outreach and Screening Initiative. The initiative
was aimed at increasing colorectal cancer screening rate.
Report includes chapters which deeply display the following deliverable about industry :
• Non-Invasive Cancer Diagnostics Market Research Objective and Assumption
• Non-Invasive Cancer Diagnostics Market Purview - Report Description, Executive Summary,
and Coherent Opportunity Map (COM)
• Non-Invasive Cancer Diagnostics Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Non-Invasive Cancer Diagnostics Market, By Regions
• Non-Invasive Cancer Diagnostics Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Non-Invasive Cancer Diagnostics Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Non-Invasive Cancer Diagnostics Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Non-Invasive Cancer Diagnostics Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Non-Invasive Cancer Diagnostics Market - Regional Analysis
On the basis of region, the global non-invasive cancer diagnostics market is segmented into
North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America
holds a dominant position in the non-invasive diagnostics market, owing to increasing incidence
of cancer, increasing technological advancement, better reimbursement scenario, and
governmental initiatives for screening of cancer in early stages. For instance, the American
Cancer Society Guidelines for the early detection of cancer offers various screening plans at
different ages. For example, the guidelines suggest that women between the age of 40 and 44
must screen for breast cancer annually.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1651
Non-Invasive Cancer Diagnostics Market – Competitive Landscape
Some of the key players operating in the global non-invasive cancer diagnostics market include
Roche Diagnostics, Hologic Inc., Qiagen, Gen-Probe Inc., Digene Corporation, Abbott Molecular,
IVDiagnostics, Laboratory Corporation of America Holdings, OncoCyte Corporation, Arquer
Diagnostics Ltd. and Affymetrix Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Non-invasive cancer diagnostics are procedures used for the identification of cancer without incision in the body.

Download Report